Learn about the applications, opportunities and challenges in this updated free white paper.
The clock shows a minute past noon. The stragglers of a steady stream of 5AMers finish sneaking in the conference room door and quickly take their seats. Someone dims the lights while another finishes pulling the shades. A hush comes over the room. “Everybody ready?” Nods answer. A mouse cursor clicks the play button. The frozen bespectacled figure on the projector screen comes to life. In a stern voice, he declares, “Integrated tests are a scam – a self-replicating virus that invades your projects! It threatens to destroy your codebase, to destroy your sanity, to destroy your life.” Another 5AM Tech Talk begins…
This year, 2000 men in the U.S. will be diagnosed with breast cancer. Fewer than 500 of them will die from the disease. In general, men's chances of developing the disease are about 100 time less that of women's. Comparatively, about 200,000 women will receive a breast cancer diagnosis.
The U.S. House of Representatives Committee on Energy and Commerce's Subcommittee on Health held a hearing entitled "21st Century Cures: Modernizing Clinical Trials" last week.
In my last post, I talked about the laboratory-developed tests (LDT), or “home brews.” LDTs are run in individual labs whose operations are regulated under Clinical Laboratory Improvement Amendments (CLIA). The home brews, however, are essentially unregulated, except in the sense that physicians and hospitals won’t recommend tests that aren’t good for their patients.
According to Murray Aitken, Executive Director of the IMS Institute for Healthcare Informatics “Social media is where the patients are.”
The Wall Street Journal reported on an in interesting development in life sciences research. Silicon Valley has begun sprouting cloud-based laboratories that could lower one of the highest barriers to entry for researchers: the cost of setting up a lab.
It isn’t exactly a problem; but it is a thing.
As I said in my introductory post to this series on the Map of Biomedicine, there’s incredible value in being to able to understand how things operate at a high level and also be able to drill down and see details. At the end of that post I showed a picture of the Map of Biomedicine that I’ve been working on. We’ll get back to talking about the overall map later, but for now I want to talk about some parts of the map in more detail. And just to answer one question up front: I’m sure this map will change. I’m guessing that in the process of writing these blog posts and fielding questions and comments, I’ll identify gaps and adjustments that will make the map more complete.
It’s been a busy June. The air is thick with buzz about healthcare data, information and engagement from both the business and consumer sides of the healthcare coin. During the first month of summer 5AM and our partners and customers saw, heard, read , and -- in some cases -- ushered in signs of momentum toward patient-centered care. Here’s our short list:
The world’s largest and most influential biotechnology gathering, the 2014 BIO International Conference, kicks off today in San Diego. BIO, the signature annual event of the Biotechnology Industry Organization (BIO) convenes biotech innovators and influencers from around the globe to explore solutions and meet service providers; gain new perspectives from thoughtful and thought-provoking leaders; find new partners and evaluate projects at all phases of development.
© 2014 5AM Solutions, Inc.All rights reserved.